Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Norihiro Takahashi is active.

Publication


Featured researches published by Norihiro Takahashi.


Hypertension | 2003

Renal sympathetic nerve responses to Tempol in spontaneously hypertensive rats

Takatomi Shokoji; Akira Nishiyama; Yoshihide Fujisawa; Hirofumi Hitomi; Hideyasu Kiyomoto; Norihiro Takahashi; Shoji Kimura; Masakazu Kohno; Youichi Abe

Abstract—Recent studies have implicated a contribution of oxidative stress to the development of hypertension. Studies were performed to determine the effects of the superoxide dismutase (SOD) mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (Tempol) on vascular superoxide production and renal sympathetic nerve activity (RSNA) in anesthetized Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR). Compared with WKY rats (n=6), SHR showed a doubled vascular superoxide production, which was normalized by treatment with Tempol (3 mmol/L, n=7). In WKY rats (n=6), Tempol (30 mg/kg IV) significantly decreased mean arterial pressure (MAP) from 108±5 to 88±6 mm Hg and HR from 304±9 to 282±6 beats/min. In SHR (n=6), Tempol significantly decreased MAP from 166±4 to 123±9 mm Hg and HR from 380±7 to 329±12 beats/min. Furthermore, Tempol significantly decreased RSNA in both WKY rats and SHR. On the basis of group comparisons, the percentage decreases in MAP (−28±4%), HR (−16±3%) and integrated RSNA (−63±6%) in SHR were significantly greater than in WKY rats (−17±3%, −9±2%, and −30±4%, respectively). In SHR, changes in integrated RSNA were highly correlated with changes in MAP (r=0.85, P <0.0001) during administration of Tempol (3, 10, and 30 mg/kg IV). In both WKY rats and SHR (n=4, respectively), intracerebroventricular injection of Tempol (300 &mgr;g/1 &mgr;L) did not alter MAP, HR, or RSNA. Intravenous administration of a SOD inhibitor, diethyldithio-carbamic acid (30 mg/kg), significantly increased MAP, HR, and integrated RSNA in both WKY rats and SHR (n=6, respectively). These results suggest that augmented superoxide production contributes to the development of hypertension through activation of the sympathetic nervous system.


Nephron | 1996

Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat.

E.N. Wardle; Isao Kurihara; Takao Saito; Katsuya Obara; Yoshiharu Shoji; Mariko Hirai; Jun Soma; Hiroshi Sato; Yutaka Imai; Keishi Abe; Shigekazu Yuasa; Mayuko Hashimoto; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Tetsuo Shoji; Koichi Uchida; Hiroshi Fujioka; Minoru Kihara; Hirohide Matsuo; Hideo Yamada; Akira Hishida; Akihiko Kato; Takashi Yoneyama; Groote Veldman; J.W. van der Pijl; F.H.J. Claas; Takanobu Sakemi; Yuji Ikeda; Noriaki Ohtsuka

20-Hydroxyeicosatetraenoic acid (20-HETE) is a major arachidonate metabolite in the kidney of the spontaneously hypertensive rat (SHR). The increase in its synthesis has been associated with the elevation of blood pressure in the SHR. The omega-hydroxylation of arachidonic acid is an activity associated with members of the CYP4A gene family which, in the rat, comprises three major isoforms: 4A1, 4A2 and 4A3. 20-HETE displays potent and diverse biological activities which can affect pro- and anti-hypertensive mechanisms dependent upon where, when and by which isoform it has been produced. Therefore, it is important to identify and characterize its biosynthetic system. We compared CYP4A mRNA and protein expression to patterns of 20-HETE synthesis in the SHR kidney. The reverse transcription/polymerase chain reaction (RT/PCR) technique was used to amplify CYP4A mRNA in microdissected nephron segments. Southern blot hybridization of PCR products obtained from nephron segments with the CYP4A1 cDNA probe demonstrated strong signals in S2 and S3 segments of the proximal tubule. Immunoblots of nephron segments using a polyclonal anti-rat liver CYP4A1 antibody which cross-reacts with CYP4A2 and CYP4A3, and 14C-arachidonic acid metabolism, confirmed that arachidonic acid omega-hydroxylation, i.e., 14C-20HETE formation, and CYP4A proteins were also localized mainly in the S2 and S3 segments. Correlation also existed between the age-dependent increase in arachidonate omega-hydroxylation in the kidney and CYP4A mRNA levels as measured by Northern hybridization of total RNA using the CYP4A1 cDNA probe. Immunoblot analysis revealed that at 7 weeks, where 20-HETE production is at its maximum, all three proteins are expressed. CYP4A3 and 4A1 immunoreactive proteins appeared at 3 weeks, showed maximum levels at 5 and 7 weeks, respectively, and gradually decreased to lower levels at 13 and 20 weeks, whereas CYP4A2 levels were undetectable at 3, 5 and 7 weeks but appeared at 13-20 weeks. Additional immunoblots indicated that renal cortical CYP4A1 protein levels were higher in SHR compared to Sprague-Dawley and Wistar-Kyoto rats. The increased levels of CYP4A1-immunoreactive band at 7 weeks corresponded to the maximal activity of arachidonate omega-hydroxylation. Thus, CYP4A1 might play a significant role in contributing to the increased cortical/proximal production of 20-HETE seen in 7-week-old SHR. However, given the high homology among members of the CYP4A gene family and the lack of specific tools to discern among these isoforms, additional studies have to be carried out to substantiate our findings.


Nephron | 1996

Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Crescentic Glomerulonephritis and Propylthiouracil Therapy

Shigekazu Yuasa; Mayuko Hashimoto; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Tetsuo Shoji; Koichi Uchida; Hiroshi Fujioka; Minoru Kihara; Hirohide Matsuo

Cutaneous vasculitis is an uncommon complication of propylthiouracil therapy. Although its pathogenesis remains to be established, detection of antineutrophil cytoplasmic antibodies (ANCA) in association with this type of vasculitis has recently been described. We report here 2 patients who developed ANCA-associated crescentic glomerulonephritis without evidence of cutaneous vasculitis during propylthiouracil treatment of hyperthyroidism. Improvement of the renal function and the disappearance of ANCA were correlately found after discontinuation of propylthiouracil and by corticosteroid therapy in both patients.


Nephron | 1996

Quenching the Thirst in Dialysis Patients

E.N. Wardle; Isao Kurihara; Takao Saito; Katsuya Obara; Mariko Hirai; Jun Soma; Hiroshi Sato; Yutaka Imai; Keishi Abe; Shigekazu Yuasa; Mayuko Hashimoto; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Tetsuo Shoji; Koichi Uchida; Hiroshi Fujioka; Minoru Kihara; Hirohide Matsuo; Hideo Yamada; Akira Hishida; Akihiko Kato; Takashi Yoneyama; Groote Veldman; J.W. van der Pijl; F.H.J. Claas; Takanobu Sakemi; Yuji Ikeda; Noriaki Ohtsuka; Yoko Ohtsuka

In a double-blind cross-over trial, 22 stable end-stage renal failure patients on maintenance haemodialysis were subjected to conventional dialysis with dialysate containing 137 mEq/l sodium and constant ultrafiltration (UF) and to a different dialysis therapy, in which, by linear sodium modelling, the dialysate sodium was reduced from 137 to 128 mEq/l. A computerized UF program was used to gradually reduce the UF to a minimum towards the end of the session. Severity of thirst, interdialytic weight gain and intradialytic complications were less with low sodium dialysate. It allowed adequate UF with absolute hemodynamic stability. The reduced incidence of complication with low sodium dialysate therapy was probably because they required less UF.


Nephron | 1996

Angiography with Nonionic X-Ray Contrast Media in Severe Chronic Renal Failure: Renal Function and Contrast Retention

E.N. Wardle; Isao Kurihara; Takao Saito; Katsuya Obara; Mariko Hirai; Jun Soma; Hiroshi Sato; Yutaka Imai; Keishi Abe; Shigekazu Yuasa; Mayuko Hashimoto; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Tetsuo Shoji; Koichi Uchida; Hiroshi Fujioka; Minoru Kihara; Hirohide Matsuo; Hideo Yamada; Akira Hishida; Akihiko Kato; Takashi Yoneyama; Groote Veldman; J.W. van der Pijl; F.H.J. Claas; Takanobu Sakemi; Yuji Ikeda; Noriaki Ohtsuka; Yoko Ohtsuka

The effects of contrast media on renal function and the cortical retention of contrast media after abdominal angiography were investigated. Sixteen nondiabetic patients with predialytic chronic renal failure received either the nonionic dimeric contrast medium iodixanol or the monomeric contrast medium iohexol in a double-blind randomized study. All patients were well hydrated before, during and after angiography. Mean 99mTc-DTPA clearance was 14.0 ml/min/1.73 m2 in the iodixanol group, and 9.3 ml/min/1.73 m2 in the iohexol group at baseline. No statistically significant changes were seen after angiography. Serum creatinine increased significantly 48 and 72 h after angiography in both groups, and then normalized. Creatinine clearance was reduced only in the iohexol group, at 72-96 h. The urinary excretion of renal enzymes and of total protein did not change significantly. No patients developed oliguria or required dialysis during the 7-day observation period. Increased attenuation in the renal cortex, measured by computed tomography and probably reflecting intracellular retention of contrast medium, peaked at 24 h, and was observed in both groups during the follow-up period. Thus, although transient and minor changes in glomerular filtration rate were noted, both iodixanol and iohexol were safe for use in angiography in nondiabetic patients with severe chronic failure when the patients were well hydrated.


Nephron | 1991

Total and Split Renal Function Assessed by Ultrasound Doppler Techniques

Takafumi Yura; Yoshihiro Takamitsu; Shigekazu Yuasa; Shigehiro Miki; Norihiro Takahashi; Hisashi Bandai; Torn Sumikura; Koichi Uchida; Toyosato Tamai; Hirohide Matsuo

We evaluated total and split renal functions from the pattern for renal arterial blood flow detected by ultrasound Doppler in healthy subjects and patients with varying degrees of renal function and disorders other than renovascular hypertension or severe aortic valvular disease. A renal-time pulsed ultrasonic echo-Doppler device at 2.5 MHz was used with a translumbar approach. The ratio of peak diastolic (D) to systolic (S) velocity correlated well with both p-aminohippurate clearance and creatinine clearance. Acceleration time was correlated with the clearance of neither compound. To evaluate the clinical usefulness of ultrasound Doppler in the assessment of split renal function, we compared the D/S ratio with the renal function obtained by radionuclide methods for individuals. The split renal glomerular filtration rate, calculated by a method which makes use of the early renal uptake of 99mTc-diethylenetriam-inepentaacetic acid, correlated well with the D/S ratio. These results indicate that the ultrasonic measurement of renal arterial blood flow by the pulsed Doppler method should be useful for assessment of total and split renal functions.


Nephron | 1996

Oxyphil Cell Function in Secondary Parathyroid Hyperplasia

E.N. Wardle; Isao Kurihara; Takao Saito; Katsuya Obara; Mariko Hirai; Jun Soma; Hiroshi Sato; Yutaka Imai; Keishi Abe; Shigekazu Yuasa; Mayuko Hashimoto; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Tetsuo Shoji; Koichi Uchida; Hiroshi Fujioka; Minoru Kihara; Hirohide Matsuo; Hideo Yamada; Akira Hishida; Akihiko Kato; Takashi Yoneyama; Groote Veldman; J.W. van der Pijl; F.H.J. Claas; Takanobu Sakemi; Yuji Ikeda; Noriaki Ohtsuka; Yoko Ohtsuka

Oxyphil cell function in secondary parathyroid hyperplasia due to chronic renal failure was evaluated using in situ hybridization and heterotransplantation of parathyroid tissue. In situ hybridization and histologic analysis were performed on continuous frozen sections using 22 parathyroid tissues. A restricted area composed exclusively of oxyphil cells was observed in 10 specimens, and an area of only chief cells was found in 12 specimens. Silver grains demonstrating the existence of parathyroid hormone (PTH) mRNA were 18.8 +/- 7.8 (mean +/- SD) in oxyphil cells while those in chief cells were 17.2 +/- 7.5. PTH mRNA was abundant in both the oxyphil and chief cells. Further analysis of oxyphil cell function was assessed by the heterotransplantation of parathyroid nodules, consisting exclusively of oxyphil or chief cells, into nude mice. The function of these implants was assessed by measuring the concentration of human intact PTH which did not cross-react with mouse PTH. Serum PTH concentrations were correlated with the volume of implanted tissue. Elevations of PTH concentrations were similar in the mice transplanted with oxyphil or chief cells, indicating that both cell types had similar PTH secretory activity. The basic histologic characteristics of both cell types were not altered following transplantation. These results demonstrate that oxyphil cells in secondary parathyroid hyperplasia synthesize and secrete PTH, and that this secretion contributes to the pathophysiology of hyperparathyroidism.


Clinical and Experimental Pharmacology and Physiology | 2000

Sodium Sensitivity And Sympathetic Nervous System In Hypertension Induced By Long-Term Nitric Oxide Blockade In Rats

Shigekazu Yuasa; Xiuping Li; Hirofumi Hitomi; Mayuko Hashimoto; Hiroshi Fujioka; Hideyasu Kiyomoto; Uchida K; Tetsuo Shoji; Norihiro Takahashi; Shigehiro Miki; Akira Miyatake; Katsufumi Mizushige; Hirohide Matsuo

1. Pharmacological inhibition of nitric oxide (NO) synthesis is known to produce acute and chronic hypertension in many animal species, but the underlying mechanisms mediating the hypertension are not completely understood. In particular, the pathogenetic roles of sodium sensitivity and the sympathetic nervous system in this model of hypertension are controversial. The present study was designed to test the hypothesis that long‐term administration of the NO synthesis inhibitor NG‐nitro‐L‐arginine methyl ester (L‐NAME) to male Sprague‐Dawley rats would produce a sodium‐sensitive hypertension and that the enhanced activity of the sympathetic nervous system in this type of hypertension contributes to the sodium sensitivity.


Nephron | 1996

Hypophosphatemia in End Stage Renal Disease

E.N. Wardle; Isao Kurihara; Takao Saito; Katsuya Obara; Mariko Hirai; Jun Soma; Hiroshi Sato; Yutaka Imai; Keishi Abe; Shigekazu Yuasa; Mayuko Hashimoto; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Tetsuo Shoji; Koichi Uchida; Hiroshi Fujioka; Minoru Kihara; Hirohide Matsuo; Hideo Yamada; Akira Hishida; Akihiko Kato; Takashi Yoneyama; Groote Veldman; J.W. van der Pijl; F.H.J. Claas; Takanobu Sakemi; Yuji Ikeda; Noriaki Ohtsuka; Yoko Ohtsuka

A case of hypophosphatemia in a 55-year-old black female on maintenance hemodialysis is described. She developed multiple bone fractures and congestive heart failure during her 10-year period on hemod


American Journal of Nephrology | 1992

Successful Resection of Pheochromocytoma in a Hemodialysis Patient

Shigekazu Yuasa; Hisashi Bandai; Takafumi Yura; Tohru Sumikura; Norihiro Takahashi; Uchida K; Noritoshi Yamamoto; Hideki Tanaka; Masaki Aono; Hiroshi Fujioka; Yumiko Kunimune; Yasufumi Miyamoto; Shigehiro Miki; Hirohide Matsuo

A 45-year-old woman with a pheochromocytoma who had been on regular hemodialysis for 4 years and underwent successful surgery is described. Careful preoperative management, including the use of prazosin and weight control, was carried out to prevent severe intraoperative and postoperative cardiovascular complications. Prazosin was given at an initial dose of 0.5 mg/day, and the dosage was increased to 20 mg/day prior to surgery. The increase in intravascular volume led to a gain of 3 kg in body weight. No deterioration of the cardiovascular or respiratory function was caused by these maneuvers, and surgery was performed without significant complications except for a rapid rise of blood pressure during tumor resection. To our knowledge, only one similar case report could be found in the English literature.

Collaboration


Dive into the Norihiro Takahashi's collaboration.

Top Co-Authors

Avatar

Shigekazu Yuasa

Kagawa Prefectural College of Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Fujioka

Kagawa Prefectural College of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Tetsuo Shoji

Kagawa Prefectural College of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Mayuko Hashimoto

Kagawa Prefectural College of Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Minoru Kihara

Yokohama City University

View shared research outputs
Top Co-Authors

Avatar

Shigehiro Miki

Kagawa Prefectural College of Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge